EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration

Julia K Banaszkiewicz iD, Anna Kukiełka, Elżbieta Kudyk, Łucja J Walczak, Katarzyna Wicha-Komsta iD, Mariola Herbet, Iwona Piątkowska-Chmiel, Grzegorz Nowicki iD, Carmen E Mielnik, Tomasz Kocki iD

Life · 03.02.2026 · 16 (2) · 266

DOI: 10.3390/life16020266 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 03.02.2026. Verfasst von Julia K Banaszkiewicz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, are becoming an increasingly serious challenge for modern medicine because of the significant increase in incidence and the narrow range of effective therapeutic strategies. In recent years, the kynurenine pathway, which is one of the main pathways of tryptophan metabolism, responsible for the synthesis of products that act oppositely in the CNS including neurotoxic (quinolinic acid) and neuroprotective products, has gained increasing recognition as a potential therapeutic target. Abnormalities in the production of these metabolites, causing a disruption of homeostasis in the CNS, often lead to the development of inflammation, which can cause oxidative stress or neuronal death. This paper aims to discuss strategies useful in modulation of the kynurenine pathway, based on increasing the production of neuroprotective metabolites and reducing the synthesis of neurotoxic compounds, as well as to outline the progress in preclinical and clinical studies and the challenges encountered in these studies, among others, in the search for new KP inhibitors. The pharmacological (IDO and KMO inhibitors) and non-pharmacological (physical activity, diet) strategies are discussed, as well as new approaches from combination and targeted therapies. Together with the results of preclinical studies, they demonstrate the high utility of this target in the treatment of neurodegeneration. Despite its promising activity, further key studies are needed to fully understand the mechanisms involved in metabolism, which may translate into increased efficacy of developed therapies in the future.

Schlagwörter

Stichwörter der Autor:innen

kynurenic acidkynurenine pathwayneurodegenerative diseases

Autor:innen und Institutionen

  • Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland.
  • Institute of Medical Sciences, Faculty of Medicine, The John Paul II Catholic University of Lublin, Konstantynów 1H Street, 20-708 Lublin, Poland.
  • Department of Family and Geriatric Nursing, Faculty of Health Sciences, Medical University of Lublin, 20-090 Lublin, Poland.
  • County Health Center in Opole Lubelskie, Przemysłowa 4a, 24-300 Opole Lubelskie, Poland.

ORCID-Profile: Julia K Banaszkiewicz, Katarzyna Wicha-Komsta, Grzegorz Nowicki, Tomasz Kocki

Zitieren

APA

Banaszkiewicz, J. K., Kukiełka, A., Kudyk, E., Walczak, Ł. J., Wicha-Komsta, K., Herbet, M., Piątkowska-Chmiel, I., Nowicki, G., Mielnik, C. E., & Kocki, T. (2026). Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration. Life, 16(2), 266. https://doi.org/10.3390/life16020266

Vancouver

Banaszkiewicz JK, Kukiełka A, Kudyk E, Walczak ŁJ, Wicha-Komsta K, Herbet M, et al. Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration. Life. 2026;16(2):266. doi:10.3390/life16020266

BibTeX
@article{Banaszkiewicz2026,
  author = {Banaszkiewicz, Julia K and Kukiełka, Anna and Kudyk, Elżbieta and Walczak, Łucja J and Wicha-Komsta, Katarzyna and Herbet, Mariola and Piątkowska-Chmiel, Iwona and Nowicki, Grzegorz and Mielnik, Carmen E and Kocki, Tomasz},
  title = {Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {266},
  doi = {10.3390/life16020266}
}
Kostenlos starten →